ENDOSCAPE is a collaborative biotechnology project consisting of 12 European partners, aimed at developing a beyond state of the art clinically applicable gene delivery technology. The ENDOSCAPE technology will have a major impact on the therapeutic opportunities for current and future drugs for a broad range of diseases and large patient groups.
The non-viral based ENDOSCAPE technology will enhance therapeutic efficacy with in a more cost-effective manner thereby reducing costs of healthcare, improving the health of patients worldwide, and strengthening the competitive landscape of the EU in the worldwide quest for such an advanced technology.
The project is funded by the European Commission under the Horizon 2020 initiative, with the grant agreement ID: 825730.
Company Details
- Founded
- -
- Address
- Berlin, De
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://endoscape-2020.eu/
- Keywords
- biotechnology, molecular biology, plant biology, pharmaceuticals, health economics, gene therapy.
- HQ
- Berlin
Endoscape Questions
Endoscape's website is https://endoscape-2020.eu/
Endoscape's LinkedIn profile is https://de.linkedin.com/company/endoscapeproject
Endoscape's industry is
Research Services
Endoscape's top competitors are
Infinit Bio,
Immutrain - Training Network For The Immunotherapy Of Cancer,
Aidd-Itn,
Cyberbiocode,
Synaptic Lab Gmbh,
Zellbio Gmbh,
Bbi-Biotech Gmbh,
Lebao_mhh,
Lifeglimmer Gmbh,
Bioprocess Engineering-Tu Berlin.
Endoscape's categories are Research Services
Endoscape's founding year is 2019
